Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors by Jonathan L Curry, Aung Naing, Joud Hajjar, Cara L Haymaker, Ken Chen, Dzifa Yawa Duose, Anisha B Patel, Omar Pacha, Nejla Ozirmak Lermi

Get full text

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 by Patrick Hwu, Cara Haymaker, Chantale Bernatchez, Marc Uemura, Adi Diab, Natalie McQuail, Elizabeth Sirmans, Faisal Faˈak, Courtney W. Hudgens, Lydia Barbara, Jonathan L. Curry, Michael T. Tetzlaff

Get full text

Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity by Xiaopeng Sun, Margaret L. Axelrod, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Violeta Sanchez, Yu Wang, Jonathan L. Curry, Elizabeth J. Phillips, Yaomin Xu, Douglas B. Johnson, Justin M. Balko

Get full text

Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib by Carlos A. Torres-Cabala, Julia Arreola Yescas, Yue Zhang, Auris Huen, Gaur Sumit, Kristy Tefft, Guilin Tang, Jonathan L. Curry, Jillian Gunther, Bouthaina Dabaja, Swaminathan Iyer, Roberto N. Miranda, Jaehyuk Choi, Valentina Nardi

Get full text

Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin: Single-Center Case Series by Mohammad Jad Moussa, Nathaniel R. Wilson, Anindita Ghosh, Meenakshi B. Bhattacharjee, Jonathan L. Curry, Woo Cheal Cho, Anisha B. Patel, Mouhammed Amir Habra, Sonali N. Thosani, Matthew T. Campbell, Arlene O. Siefker-Radtke, Omar Alhalabi, Nupur J. Kikani

Get full text